Optimal Timing of Complete Revascularization in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis.

Long‐Term Clinical Events When data were pooled among trials, the risk of the composite outcome MACE in the single‐stage complete revascularization treatment arm was consistently lower than that in the multistage PCI arm at 6 months (RR, 0.67; 95% CI, 0.40–1.11) (Figure 2 ) and at longest follow‐up (RR, 0.79; 95% CI, 0.52–1.20) but did not reach statistical significance (Figure 3 ).

also in 111,027 other papers